Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Prisma Health-Upstate, Greenville, South Carolina China
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou Zhejiang Provincial Cancer Hospital, Hangzhou Xuzhou Central Hospital, Xuzhou Yantai Yuhuangding Hospital, Yantai Southern Medical University Zhujiang Hospital, Zhujiang Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City